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Analysis of tumour cell composition in tumours composed of paired
mixtures of mammary tumour cell lines
B.E. Miller, F.R. Miller, D.J. Wilburn & G.H. Heppner
The E. Walter Albachten Department ofImmunology, Michigan Cancer Foundation, 110 E. Warren Avenue, Detroit, MI 48201,
USA.
Summary In order to quantitate the effects of tumour subpopulation interactions, we have devised a method
to determine the subpopulation composition of tumours by using paired tumour cell lines able to grow in
different selective media. Line 4T07 forms colonies in thioguanine but not in HAT and line 168 forms
colonies in HAT but not in thioguanine. An independent technique of determining tumour cell content was
used to validate this method: line 168 and 4T07 cells are distinguishable by flow cytometry after staining with
propidium iodide for DNA content. Mixtures of cell suspensions prepared from each unmixed tumour, as
well as from tumours arising from mixtures of these lines, were analysed by both the colony formation assay
and by the DNA content assay. The colony formation assay yielded values in good agreement with the DNA
content assay, but was considerably more sensitive in that it was able to quantitate minority subpopulations
that constituted < 10% of the tumour. Both methods revealed that in tumours arising from mixtures, the
tumour cells were almost entirely line 4T07, even when the inoculum had contained a high proportion of 168
cells. Since line 168 cells are very tumorigenic per se, these results suggest that line 4T07 cells are capable of
interfering with 168 proliferation in mixed tumours, either directly or through a host-mediated mechanism.
Evidence for the existence of multiple, clonal subpopulations
of tumour cells within single neoplasms has been demon-
strated repeatedly by many laboratories, including our own
(Dexter & Calabresi, 1982; Fidler & Hart, 1982; Poste &
Grieg, 1982; Heppner & Miller, 1983; Heppner, 1984). We
have been working with a series of tumour subpopulations
derived from a single mammary tumour which arose in a
strain BALB/cfC3H mouse (Dexter et al., 1978; Heppner et
al., 1978). We have demonstrated that these subpopulations
differ in a number of characteristics, including growth
properties in vivo and in vitro (Dexter et al., 1978; B.E.
Miller et al., 1980; F.R. Miller et al., 1981), propensity to
metastasize (F.R. Miller et al., 1983), and intrinsic sensitivity
to chemotherapeutic agents (Heppner et al., 1978; B.E.
Miller et al., 1981; B.E. Miller et al., 1983a; B.E. Miller et
al., 1984). These experiments illustrate the enormous vari-
ability in behaviour of which tumour cells of similar origin
are capable when isolated from each other. In order to
determine whether these characteristics of individual sub-
populations are retained when they are grown in the
presence of other subpopulations rather than in isolation, we
have studied the behaviour of mixtures of subpopulation
lines. We have found that characteristics of an individual
subpopulation such as growth rate (B.E. Miller et al., 1980;
Heppner et al., 1980), metastatic capability (F.R. Miller,
1983), and drug sensitivity (B.E. Miller et al., 1981; B.E.
Miller et al., 1983b; B.E. Miller et al., 1986), can be
influenced by the presence of another subpopulation.
Studies of tumour subpopulation interactions require a
method to quantitate the number of cells of each subpopu-
lation in a mixed tumour. This, in turn, requires markers by
which each population can be identified. Although some of
our subpopulations differ in regard to suitable markers, such
as DNA content, we have been limited in the types of
analyses we could do. To overcome this problem, we have
inserted genetic markers into several of our subpopulation
lines (B.E. Miller et al., 1983b; B.E. Miller et al., 1986), so
we can identify individual subpopulations in mixed tumours
by colony formation in selective media. We here demonstrate
the usefulness of these 'marked' cell populations in deter-
mining the cellular composition of tumours arising from
mixtures of two subpopulation lines. In order to confirm
that our analysis of tumour composition by colony
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formation in selective media yields accurate values, we
analysed tumour cell suspensions both by colony formation
and by identifying individual cells by their DNA content,
determined by fluorescence analysis of propidium iodide-
stained cells by flow cytometer. For these experiments we
used tumour cell line 168, which is approximately tetraploid,
and tumour line 4T07, which has a higher than tetraploid
DNA content, in mixtures. These two cell lines can be
distinguished from each other and from diploid host cells by
DNA content. They can also be distinguished by cloning in
medium containing hypoxanthine, aminopterin, and
thymidine (HAT medium) and in medium containing 60pM
thioguanine. Line 4T07 is derived from line 44FTO, and has
retained the hypoxanthine, guanine-phosphoribosyltrans-
ferase (HGPRT)-negative phenotype distinguished by ability
to grow in the presence of thioguanine but not in HAT (B.E.
Miller et al., 1986). Line 168 is HGPRT positive, and thus
can grow in HAT but not in the presence of thioguanine
(B.E. Miller et al., 1983b).
Materials and methods
Cell lines
Cell lines 168 and 410.4 were isolated from a single, spon-
taneously arising mammary tumour of a BALB/cfC3H
mouse (Heppner & Miller, 1983; Blazar et al., 1980). The
thioguanine-resistant, ouabain-resistant cell line 44FT0 was
isolated from line 410.4 after mutagenesis with ethyl
methanesulfonate (B.E. Miller et al., 1986). Line 4T07 was
derived from line 44FT0 by the following procedure:
cultured line 44FT0 cells were injected i.v. at 106 cells per
mouse into 3 syngeneic mice. In 6 weeks, after the mice
became moribund, they were sacrificed, and a portion of the
lungs of one mouse which contained several gross metastases
was removed, teased apart, and plated in medium containing
60pM 6-thioguanine. After 10 days in culture, these cells
(4T01) were resuspended and injected i.v. as before. The
entire process was repeated 6 times. Starting at passage 5,
the cell number injected was reduced to 5 x 105 per mouse.
The time required for mice to become moribund shortened
to - 3 weeks.
Mice
Male BALB/c mice, 8-10 weeks old, were produced in our
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animal colony, from a BALB/c breeding colony established
by Cesarean derivation of a litter of mice from BALB/cfC3H
parents obtained from the Cancer Research Laboratory,
Berkeley, CA, USA.
Tumours
Cells from monolayer culture were suspended in Hank's
buffered salt solution and injected s.c. into mice in a volume
of 0.1 ml. Tumours were measured twice a week in two
perpendicular dimensions with Vernier calipers. Mice were
sacrificed and their tumours aseptically removed for cell
suspension at various sizes ranging from 245 to 4,332mm3
(21-47 days after injection). Tumour size in mm3 was
calculated by the formula axb2÷2, where b is the smaller
and a the larger of the two tumour dimensions.
Tumour cell suspension
Tumours were cut into pieces with scalpels, digested for 1 h
with 2mgml-1 collagenase, type III (Cooper Biomedical,
Malvern, PA, USA) and 1 mgml-1 hyaluronidase (Sigma
Chemical Co., St. Louis, MO, USA), centrifuged to pellet
cells, resuspended, and further digested for 15 to 20min with
12.5mgml-1 protease type IX (Sigma Chemical Co.). Cells
were pipetted up and down several times to break up
clumps, rinsed and resuspended in Dulbecco's Modified
Eagle medium (DME) supplemented with 2mM glutamine,
penicillin (10 Uml-1), streptomycin (100l gml-), mixed
nonessential amino acids (1 mM), and 10% foetal bovine
serum. Cells were passed 3 to 4 times through a 22g needle
to form a single cell suspension, and counted by haemo-
cytometer. A small portion of each cell suspension was
removed for the colony forming assay, while the rest of each
suspension was prepared for analysis using the fluorescence
activated cell sorter (FACS). Cell viability was routinely
measured by trypan blue exclusion. Percent viable cells
ranged from 8 to 82% in different tumours; the mean
viability ±s.d. for 168 tumours was 48 +22%; for 4T07
tumours, 35+ 16%; for mixed tumours, 35+ 14%.
FACS analysis ofcellular DNA content
Cells were recentrifuged, resuspended in PBS, pH 7.6, at
2 x 106 cellsml-1, chilled to 0WC, and fixed by slowly adding
an equal vol of ice-cold 100% ethanol. Cells were kept
overnight at 4°C, then recentrifuged and incubated for
30min at 37°C in 0.5ml RNase (Sigma Chemical Co.),
13.5mgml-l in PBS. Cells were collected by centrifugation,
suspended in propidium iodide (50pgml-1) in PBS, and
stored in the dark at 4°C until analysis (within 4h). Analysis
was performed on a Becton-Dickenson FACS 40 flow
cytometer with a Consort 40 data acquisition package.
Cell suspensions prepared from mouse spleen, used as a
diploid cell control, were prepared by mechanical dispersion
and RBC lysis as previously described (B.E. Miller et al.,
1985). Cells were fixed and stained as described for tumour
cells.
Colonyforming assay
Selective media were thioguanine medium (DME supple-
mented as above, containing 60 M 6-thioguanine) and HAT
medium (supplemented DME containing 100 M hypox-
anthine, 0.4yM aminopterin, and 16pM thymidine). Cells
were diluted and plated in supplemented DME at 200 and
1,000 viable cells per well (occasionally, at 5,000 viable cells
per well also) in 6-well tissue culture plates containing an
equal volume of selective medium 2-fold concentrated in
selective agent. After 8-10 days, colonies were fixed in
methanol-acetic acid, stained with crystal violet, and counted
with the aid of a dissecting microscope.
Determination ofcellpercentagefrom colony data
For each of three experiments, the colony forming
efficiencies of viable cells of 4 to 7 168 tumour cell sus-
pensions and the colony forming efficiencies of viable cells of
4 to 9 4T07 tumour cell suspensions were determined in both
HAT and thioguanine medium. In all experiments, no
colonies were formed from 168 tumour suspensions plated in
thioguanine, whereas 4T07 tumour suspensions plated in
HAT with an average colony forming efficiency of 0.005%.
Most of these colonies were probably host cells, because (a)
the colony forming efficiency in HAT medium of 4T07 cells
from culture is <0.002%, and (b) the morphology of these
colonies and the cells within them differed from 4T07
colonies and cells. Few of these colonies are likely to be
HGPRT-positive revertants or fusion products between 4T07
and host cells, because 4T07 tumour suspensions do not
form colonies in medium containing HAT plus ouabain. The
colony forming efficiency of an individual 168 tum'our cell
suspension in HAT, and of an individual 4T07 tumour cell
suspension in thioguanine medium, was used to analyse the
percentage of each cell line existing in each mixture of the
two cell suspensions, by using the following formulas:
xP = colony forming efficiency of the mixture in
thioguanine.
y(l -P) = colony forming efficiency of the mixture in HAT.
colony forming efficiency in HAT
of the line 168 tumour suspension
y = x colony forming efficiency in thioguanine
of the line 4T07 tumour suspension
in which:
x is the colony forming efficiency of 4T07 cells in the
mixture in thioguanine,
y is the colony forming efficiency of 168 cells in the
mixture in HAT, and
P is the proportion of tumour cells which are 4T07.
To analyse mixtures existing in tumour cell suspensions
from tumours arising from injection of mixtures of the two
cell lines, we determined the mean colony forming efficiences
of all the 168 tumours and 4T07 tumours from the same
experiment (n=6 to 9). These values were used to determine
the relationship between x and y, as:
mean colony forming efficiency in
HAT of all line 168 tumours
y x mean colony forming efficiency in
thioguanine of all line 4T07 tumours
Results
Analysis ofmixtures oftwo tumour cell suspensions by DNA
content and by colonyformation
We began our analysis of tumour cell content by making
mixtures of cell suspensions prepared from homogeneous
tumours. In Figure 1 are shown DNA histograms for a
normal spleen (Panel A), a typical line 168 tumour (Panel
B), a typical line 4T07 tumour (Panel C), a mixture of the
two tumour cell suspensions (Panel D), and two tumours
resulting from injecting a mixture of 168 and 4T07 cells
(Panels E and F). Vertical lines represent windows used to
classify cells in each category by DNA content. Spleen cells
were used as controls to set the DNA content of diploid cells
in each experiment. It is clear that diploid cells in G1 can be
clearly distinguished from both tumour cell types, and that
the two types of tumour cells can be distinguished from each
other fairly well despite some peak overlap. However, the
host cells in G2 can not be distinguished from tumour cells
and are a significant source of error in estimating the
content of a minor tumour population (Figure 1, Panel F).CELL COMPOSITION OF HETEROGENEOUS TUMOURS 563
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Figure 1 DNA histograms from spleen cells and from tumour cell suspensions. Panel A: tumour bearer spleen. Panel B: line 168
tumour suspension. Panel C: line 4T07 tumour suspension. Panel D: 1:1 cell mixture of suspensions from C and D. Panel E:
suspension of cells from a tumour which arose from injection of a 1:1 mixture of 168 and 4T07 cells. Panel F: a second tumour
arising from injection of the same 1: 1 mixture. Vertical lines mark the windows used to classify cells by DNA content: 1, diploid
cell window; 2, line 168 cell window; 3, line 4T07 cell window. The vertical axis differs in each panel; in A and F, full scale equals
4000; in B, 1400; in C, 2100; in D, 1600; in E, 3000.
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The DNA content per cell of 168 tumour cells was 1.95
times that of spleen cells, and that of 4T07 tumour cells was
2.36 times that of spleen cells. These values are the same as
those determined for the GO/G1 peak of the same tumour
cell lines in culture (not shown). In the tumour cell
suspensions shown here and in other tumours analysed (a
total of 65 tumours), 73 to 90% of the cells analysed were
found in the appropriate windows. Other cells were generally
scattered throughout the histogram. In some tumours, small
peaks could be distinguished at higher DNA levels, which
may represent dividing tumour cells, doublets, triplets,
and/or cell fusions. Because none of these peaks contained
more than 4% of the cells, they were ignored in subsequent
analyses.
We also carried out colony forming assays with mixtures
of cells from suspensions prepared from homogeneous
tumours. In a series of experiments, we prepared cell
suspensions from line 168 tumours and 4T07 tumours, mixed
these in 9:1, 1:1, and 1:9 cell ratios, and analysed samples of
each original suspension and mixture by measuring colony
formation in selective media and by DNA content (FACS
analysis) to determine the percent of tumour cells which were
4T07. These data are shown in Table I. The FACS data were
analysed in two ways: (a) the percent tumour cells vs. normal
Table I Analysis of mixtures of cell
cells in the unmixed suspensions was determined, and these
data were used to calculate the expected percent of line 4T07
cells in mixtures (Column 1, Table I); and (b) the mixture
itself was analysed by FACS and the 4T07 cell content
determined directly (Column II, Table I). These two values
agreed well for some mixtures, although in experiment 3 and
4, the percent 4T07 measured directly (II) was considerably
lower than that expected (I) in mixtures with high 4T07.
These anomalous data were both obtained in a single day.
Further analysis of data from these experiments revealed
that there was an apparent shift of cells from the diploid
peak to the tetraploid (168 tumour cell) peak in mixtures
compared to that expected. This shift had the effect of
increasing the percent cells classified as 168, thereby de-
creasing the percent classified as 4T07. The reason for this
shift is unknown. Presumably, clumping (dimer formation)
of host cells occurred in these samples after mixing the
tumour suspensions. In experiment 5, at low 4T07, the
measured percent 4T07 was considerably higher than
expected. The 168 peak of this sample was quite broad and
therefore difficult to analyse. At any rate, data obtained by
FACS analyses were responsive to the known dosage of
4T07: mixtures known to contain fewer numbers of 4T07
cells were analysed as such. On an additional 5 pairs of
suspensions prepared from homogneous
nours
Percent oftumour cells which werefound to be 4T07:
from analysis
from FACS analysis colonyformation
Cell mixture Experiment
168:4T07 numbera I. Expected' II. Observed' IlLd
9:1 1. 5.5 10 19
2. 6.9 14 15
3. 6.7 4.4 22
4. 2.9 4.1 14
5. 14 32 8.3
6. 2.5 4.1 9.1
Mean+s.d. 6+4 11+11 14+5
1:1 1. 34 34 50
2. 40 51 52
3. 39 23 38
4. 21 5.9 39
5. 59 64 49
6. 19 14 57
Mean+s.d. 35+ 15 32+22 48+8
1:9 1. 83 68 90
2. 86 88 92
3. 85 47 88
4. 71 26 82
5. 93 84 73
6. 68 44 90
Mean+s.d. 81+10 60+24 86+7
aEach experiment used a different pair of tumours; bTumour suspensions before
mixing were analysed by FACS for tumour cell vs. diploid cell content, and the
expected percent of tumour cells which were 4T07 in mixtures was determined from
this data; cTumour suspensions after mixing were anlysed by FACS, and the percent
of cells in the 4T07 peak was calculated as a percent of the cells in the 4T07 peak
plus the 168 peak; dTumour suspensions after mixing were analysed for colony
formation in thioguanine medium and in HAT medium, and the percent of tumour
cells which were 4T07 was determined as described in Materials and methods. The
colony forming efficiency used for each cell line in each mixture was that determined
for the actual tumour used to make up the mixed suspension.
Footnote Tumours arising from injection of line 168 cells or line 4T07 cells were
removed, and single cell suspensions were prepared and counted by haemocytometer.
No attempt was made to distinguish between tumour cells and other cells such as
lymphocytes in haemocytometer counts. Cell suspensions were mixed in ratios as
shown, and a sample of each suspension was removed for cloning in selective media.
Another sample of each suspension was processed for FACS analysis.CELL COMPOSITION OF HETEROGENEOUS TUMOURS 565
tumours analysed by FACS only, similar relationships were
found (mean+s.d. for method I vs. II: at 9: 1, 6+3 vs.
11+5; at 1:1, 35+10 vs. 41+20; at 1:9, 82+6 vs. 73+8).
Likewise, colony formation experiments yielded data
which were responsive to the known dosage of 4T07. Colony
data were in fair agreement with FACS data but tended to
yield a higher percent of 4T07. In order to test whether the
higher proportion of 4T07 cells was due to an unexpected
influence of one subpopulation upon the other in the selec-
tive media, we mixed cells from 168 tumour suspensions (200
to 1,000) with 1,000 cells from 4T07 tumour cell suspensions
and allowed them to form colonies in HAT. Similarly, we
mixed various numbers of cells from 4T07 tumour cell
suspensions with 1,000 cells from 168 tumour cell sus-
pensions and allowed them to form colonies in thioguanine.
The colony forming efficiences of neither cell line was
affected by the presence of the other (Table II). We also
added 6 to 50 cells of one type from culture with 103 to 105
cells from tumour suspensions of the second type and plated
the mixtures in selective media. These experiments revealed
that either minority population could be quantitatively
detected even when constituting <0.6% (6 in 103) of the
total cell number (Figure 2, Panels A and B). In thioguanine
medium, line 4T07 could also be detected when it constituted
as little as 0.006% (6 in 105) of the total cells (Figure 2,
Panel B), but line 168 colonies could not be distinguished in
plates containing 105 line 4T07 tumour suspensions in HAT
medium because a lawn of cells was formed in these plates.
In this experiment, unlike those of Table II, line 168 cells
from culture, which had a high colony forming efficiency in
HAT medium, had a slightly lower colony forming efficiency
in the presence of 4T07 tumour cell suspensions (Panel A).
In contrast, line 168 tumour suspensions had little effect on
the colony forming efficiency of line 4T07 cells in thio-
guanine medium (Panel B). It may be that in some experi-
ments, line 168 is underestimated in the colony formation
assay because its actual colony forming efficiency in mixtures
is somewhat smaller than it is assumed to be.
From the DNA content assays we were able to determine
the percentage of diploid (host) cells in tumours of each
type. These data are shown in Table III. Line 4T07 tumour
suspensions had a much higher diploid cell content than did
line 168 tumours.
Analysis of tumours arisingfrom injection ofmixtures of two
cell lines
The results with mixtures of homogeneous tumour cell
suspensions encouraged us to use FACS analysis and colony
Table II Colony-forming efficiency of tumour cells when alone and
when mixed with cells from another tumour
Tumour suspensions Colony-forming efficiency (%)
168 cells plated in HAT alone with 4T07 added
1. 1.7+0.6 (9)a 1.8+0.5 (9)
2. 6.1+1.6 (9) 5.9±2.4 (9)
3. 9.4+2.1 (6) 7.4+1.6 (6)
4. 4.7+1.2 (12) 5.2±1.5 (12)
4T07 cells plated
in thioguanine alone with 168 added
1. 9.4+2.7 (9) 8.3+4.3 (9)
2. 14.4+4.8 (12) 14.4±2.9 (12)
3. 7.5+1.7 (12) 7.1+1.6 (12)
4. 6.0+ 1.4 (12) 7.7+2.4 (12)
aMean +s.d. (number of plates).
Footnote Four 168 tumour suspensions and four 4T07 tumour
suspensions were plated at 200 to 1,000 cells per plate in selective
medium, either alone or with the addition of 1,000 cells of tumour
suspension from the other tumour cell type.
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Figure 2 Colony formation of line 168 cells or line 4T07 cells in
selective media in the presence of an excess of the other cell line.
Panel A: Line 168 cells from culture plated at the number shown
in 60mm dishes in HAT medium either alone (@) or in the
presence of 103 added cells from a 4T07 tumour suspension (0).
Panel B: Line 4T07 cells from culture in thioguanine medium
either alone (0), with 103 added cells from a 168 tumour
suspension (O), or with 105 added cells from a 168 tumour
suspension (A). Points, means of 6 replicates; lines, s.e.
Table IHI Diploid (host) cell content of tumours
determined by FACS analysis
Diploid cell content
Tumour cells injected (% oftotal cells)
168 27+7 (18)a
4T07 54+13 (16)
168:4T07 mixture
1:1 55+ 11 (10)
3:1 69+13 (7)
9:1 59+6 (7)
19:1 67+9 (7)
aMean+s.d. (number of tumours).
Footnote Tumours arising from injection of
3 x 105 cells, either 168 cells, 4T07 cells or mixtures
of the two, were removed, suspended, propidium
iodide-stained, and analysed by FACS.
formation in selective media to identify these sublines in
heterogeneous tumours. We analysed a series of tumours
arising from injection of mixtures of 4T07 and 168, at
different ratios, by both FACS and colony forming assays.
These results are shown in Table IV. There was a strong
tendency for tumours to contain a higher percentage of 4T07
than that injected. Only in 2 of the 7 tumours initiated with
19 times as many 168 cells as 4T07 cells were <90% of the
tumour cells identified as 4T07 (Table IV). Both techniques
detected the same two tumours, one of which contained 39%
4T07 by the colony forming assay, and 50% 4T07 by FACS
analysis, whereas the second tumour contained -85% 4T07
cells by both techniques.566 B.E. MILLER et al.
Table IV Analysis of tumours arising from mixtures of 168 and
4T07 cells
Fraction oftumours in which the
tumour cells were <90% 4T07:
168:4T07 cell
ratio injected by colonyformation by FACS analysis
1:1 o/1ir 1/10j
3:1 0/6 0/6
9:1 0/7 0/7
19:1 2/7C 2/7
aNumber of tumours <90% 4T07/total number of tumours
analysed; "Tumour cells analysed as 99% 4T07 by colony assay,
83% by FACS; cFirst tumour analysed as 85% 4T07 by colony
assay, 84% by FACS. Second tumour analysed as 39% 4T07 by
colony assay, 50% by FACS.
Footnote Tumours arising from injection of 3 x 105 total cells
were removed, suspended, and assayed by both colony formation
and FACS analysis.
Tumours containing .90% 4T07 cells could not be
further distinguished from each other by FACS because of
the broad 4T07 peak overlapping the 168 region of the DNA
histogram, because of background noise, and because of host
cell G2 overlap with 168 peak (Figure 1, Panel F). The more
sensitive colony forming assay, however, allowed a more
precise determination of the 168 cell content in these
tumours. In tumours arising from a 1:1 injected cell ratio, 6
of 10 were >99.5% 4T07, 3 of 10 were 99%. Similarly, in
tumours arising from a 3:1 cell ratio, 3 of 6 were >99.5%,
and 3 of 6 were 99%. In tumours arising from 9:1 initial cell
ratios, a few more 168 cells could be detected: 2 of 7
tumours were .99.5% 4T07, and the remaining tumours
were 99, 99, 97, 94, and 93%. In tumours arising from 19: 1
cell ratios, 3 of 7 were .99.5% 4T07, and the remainder
were 97, 92, 85, and 39%.
Although on average we harvested line 168 tumours earlier
than line 4T07 tumours (Table V), because of their extremely
rapid growth, line 168 tumours tended to be bigger than line
4T07 tumours at the time of harvest (Table V). There was
also a larger size range of 168 tumours analysed. Since we
used the mean colony forming efficiencies of the unmixed
tumours to determine the composition of tumours arising
from mixtures, it was important to determine whether the
tumour size or day of harvest affected the colony forming
efficiency within each group. Multiple regression analysis
was used to examine relationships between the colony
forming efficiencies of cell suspensions from unmixed
tumours in HAT or in thioguanine media, or the percent
tumour cells obtained by FACS analysis, with tumour size
or day of harvest. No significant correlations were found for
either tumour group. Neither were colony forming efficiences
significantly correlated with percent tumour cells in either
group. In the tumours arising from mixtures, we tested
whether the proportion of tumour cells found to be 4T07
9-
E
E
0
E
400
0 1(
Days after injection
Figure 3 Growth of line 168 tumours, line 4T07 tumours, and
tumours arising from mixtures of the two injected at a 19:1
168:4T07 ratio. A total of 3 x 105 cells were injected s.c. in 0.1 ml
Hank's buffer in each group (10 mice per group). Points, means;
Lines, s.e. Line 168, 0; 4T07, 0; mixture, A.
was correlated with tumour size or day of harvest within
each group. In the 3:1, 9:1, and 19:1 mixtures, these
variables were not significantly correlated, but in the 1:1
mixtures the proportions of 4T07 were significantly
negatively correlated with day of tumour harvest.
The overgrowth by line 4T07 in mixtures with line 168
would not be expected from examination of the growth rates
of the individual tumours (Figure 3). Although line 168 has
Table V Size and day of harvest of tumours used in the study
Number oftumours Tumour size at harvest
Tumour type analysed (mm3) Day ofharvest
168 17 1,802+293 (245-4,332)a 28 (21-36)b
4T07 22 738+68 (320-1,800) 38 (21-43)
168:4T07 mixtures
1:1 20 825+65 (486-1,666) 34 (28-47)
3:1 6 697+98 (405-1,080) 28 (21-38)
9:1 7 814+65 (650-1,080) 35 (28-38)
19:1 7 497+63 (288-786) 28 (21-28)
aMean+s.e. (range); bMedian (range).
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a somewhat longer latency period than does line 4T07, it is a
rapidly growing tumour, and would be expected to be the
dominant tumour cell by the time of tumour harvest if the
cells from mixtures grew independently of one another. Also
shown in Figure 3 is the growth curve for tumours arising
from injection of mixtures of line 168 plus line 4T07 at a
19:1 cell ratio. The growth of these tumours more closely
resembles that of line 4T07. The one tumour of this group
which was found to contain 39 to 50 percent 4T07 tumour
cells when harvested at day 28, could not be distinguished
from the other tumours in its group by growth rate early
after injection, but was growing rapidly at the time of
harvest.
The diploid host cell content of the tumours arising from
mixtures (Table III) was high, as might be expected of
tumours which were essentially all 4T07 cells.
Discussion
We have established a series of mouse mammary tumour cell
lines, all derived from the same tumour, which contain drug
resistance markers, enabling individual cells to be quan-
titated in mixtures of cells from tumours or from in vitro
cultures (B.E. Miller et al., 1983b; B.E. Miller et al., 1986).
As we describe here, the proportion of each cell line in cell
suspensions containing both line 168 and line 4T07 can be
determined in mixtures because line 168 (wild type) is able
to grow in medium containing HAT but not in medium
containing 60juM thioguanine, whereas line 4T07 (HGPRT-
negative) can grow in thioguanine but not in HAT. In
suspensions of cells from tumours, these two types of
tumour cells can be distinguished from normal host cells in
the colony forming assay because of the much higher colony
forming efficiency of the tumour cells under the assay
conditions used.
Unfortunately, when we assayed a series of tumours by
this method, the total colony forming efficiency (sum of
colony forming efficiencies in both media) varied widely
from tumour to tumour in tumours arising from either cell
line, and in tumours arising from mixtures, so we could not
determine directly the actual colony forming efficiency of
each cell line within tumours arising from mixtures. The
range of colony forming efficiencies for 22 4T07 tumours in
thioguanine was 1.2 to 30.0% (mean, 10.7%). The range of
colony forming efficiencies for 17 168 tumours in HAT was
1.7 to 20.5% (mean, 8.0%). Therefore, we needed some
estimate of the colony forming efficiency of each cell line in
mixtures in order to determine the cell proportions from
colony numbers. We assumed that the ratio between the
colony forming efficiencies of lines 168 and 4T07 remained
constant in all tumours containing cell mixtures (i.e., we
assumed that whatever factors caused one tumour to have a
lower total colony forming efficiency than another tumour,
these factors would affect both cell lines proportionally, so
that colony forming efficiencies of both cell lines would be
lower but remain in the same ratio). We also assumed that
this ratio was the same as that found between the mean
colony forming efficiencies of the two cell lines in
suspensions from unmixed tumours.
The colony formation assay does not require that the cell
lines being analysed differ in DNA content. However,
because these two cell lines can also be distinguised from
each other and from normal host diploid cells in tumour cell
suspensions by their DNA content, we were able to test the
validity of the above assumptions by assaying the same
mixtures by the DNA content assay. As we have shown,
there was good agreement between the two assays.
The DNA content assay is somewhat more straight-
forward than the colony formation assay, because it
identifies cells directly. However, errors in cell identification
leading to miscalculation of cell proportions occur in this
assay, as well. In some tumour cell suspensions, up to 27%
of the stained particles counted (average, 21%) did not fall
into one of the major peaks. These non-identified particles
are most likely doublets, cells in cycle, and debris. They may
be more likely to be formed from one cell line than another.
Also, there is significant overlap of host G2 and G, peaks of
168 and 4T07, making precise determination of their pro-
portions impossible. Both of these problems greatly lower
the sensitivity of this technique. We estimate that neither cell
line can be detected accurately in mixtures unless it is at least
10% of the total tumour cells. If the DNA peaks were
farther apart, the sensitivity would be increased but the
background noise would still limit sensitivity.
The colony formation assay can detect cells which make
up only a very small proportion of the total. In the case of
this pair of cell lines, the sensitivity of detection of line 168
in mixtures which are predominantly line 4T07 is somewhat
limited, because line 4T07 tumour suspensions form colonies
at low frequency (0.005%) in HAT medium. We estimate
that line 168 can be detected if it is at least 0.5% of
mixtures. However, line 4T07 should be detectable in
mixtures which are predominantly 168 with much greater
sensitivity, merely by plating more cells. One should be
limited only by the need to plate cells at low density to
prevent metabolic cooperation. The ability of normal host
cells to form colonies in medium containing 60 iM
thioguanine should be extremely small.
Of course, both assays only measure the proportion of the
two cell lines in cell suspensions. One or the other cell line
may be more fragile under the conditions used to disperse
the tumours.
Since both the tumour lines used here have distinctive
DNA content greater than that of diploid mouse cells, the
DNA content assay also allowed us to quantitate the
number of host cells in the tumour samples. The percent of
diploid cells in tumours of each type agrees well with the
determination of infiltrating host cells by other methods. Our
laboratory has found suspensions of 168 tumours to be 12%
anti-lymphocyte serum positive (Rios et al., 1983) and 19%
Fc receptor positive (Loveless & Heppner, 1983). The sum of
these values (31%), agrees very well with the proportion of
diploid cells (28%) reported here. We did not determine
these values for line 4T07, but line 410.4, the parent line of
4T07, is 38% anti-lymphocyte serum sensitive (Rios et al.,
1983), and 24% Fc receptor positive (Loveless & Heppner,
1983). This sum (62%) also agrees very well with the
proportion of diploid cells (54%) determined for line 4T07.
The purpose of developing these methods in our
laboratory was to be able to quantitate tumour
subpopulation interaction within heterogeneous tumours.
When mixtures of the two cell lines were injected, the
tumour cells which grew out were almost entirely line 4T07,
even when we injected a large excess of line 168. Although
line 168 tumours have a somewhat longer latency period
than line 4T07 tumours, line 168 produces rapidly growing
tumours. At the time of tumour harvest, we would not
expect either cell line to predominate. It is clear that there is
a strong interaction of some kind between tumour cells or
between host and tumour which strongly favours the growth
of line 4T07 over line 168. We are currently investigating the
mechanism of this interaction.
Previously, we reported that line 410 tumours could
inhibit the growth of line 168 tumours when the two
tumours were growing on opposite sides of the same mouse
(B.E. Miller et al., 1980). This interaction, which apparently
was due to an immune response to line 410 which, when
mounted, could recognise and inhibit the growth of both line
410 and line 168 (Miller et al., 1980), is not the same as the
interaction between 168 and line 4T07 described here.
Inhibition of line 168 by line 4T07 is very weak when the
two cell lines are not in contact, and it appears to take place568 B.E. MILLER et al.
in vitro under some culture conditions (B.E. Miller &
Heppner, manuscript in preparation). The two-site protocol
was necessary in investigating interactions between lines 168
and 410 because we were unable to quantitate those lines in
mixtures. The existence of 'genetically marked' subpopu-
lation lines overcomes this limitation and allows the study of
interactions which depend upon cell contact.
Leith et al. (1985) have also described a system of artificial
heterogeneous tumours which they have constructed by
injecting 1:1 mixtures of two human colon tumour lines,
originally isolated from the same tumour, into nude mice.
They identified the proportions of the two lines in the
tumours which grew out by colony morphology. They found
that over time, one cell line overgrew the other, until the
tumours appeared to stabilize at a 9:1 mixture of the two
cell lines. Other interactions in which the growth of a sister
subpopulation is suppressed have been described both in
vitro (Heppner et al., 1980) and in vivo (B.E Miller et al.,
1980; Caignard et al., 1985; Newcomb et al., 1978) by
mechanisms invoking host immtune involvement (B.E. Miller
et al., 1980; Caignard et al., 1985; Newcomb et al., 1978)
and by mechanisms not involving host immunity (Heppner
et al., 1980). Interactions in which the growth of a sister
subpopulation is enhanced, have also been described (Caig-
nard et al., 1985; Brodt et al., 1985; Butler et al., 1983;
Tofilon et al., 1984), as well as, in some instances, the
tendency for two subpopulations to form a particular final
ratio (Leith et al., 1985; Jansson & Revesz, 1976).
We feel that the cell lines and the method of analysis
described here will be extremely useful in determining the
impact of subpopulation interactions on the growth of
heterogeneous tumours. In addition, by injecting cell
mixtures whose components are differentially sensitive to a
given chemotherapeutic agent, we can measure directly the
effect of chemotherapy on heterogeneous populations. We
have already demonstrated that interactions between cell
populations can affect their response to chemotherapy in
vitro and in vivo (B.E. Miller et al., 1981), but we were
limited to assay methods which did not allow cells to come
in contact. Now that we have available appropriate cell lines
and an assay system for identifying these cell lines in
mixtures, we can examine such interactions in tumours
arising from mixtures ofcells.
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